secwatch.observer — SEC 8-K summary
======================================

Issuer:     NRX Pharmaceuticals, Inc. (NRXP)
CIK:        0001719406
Form:       8-K
Filed at:   2024-06-20T23:59:59+00:00
Accession:  0001558370-24-009369
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NRx Pharmaceuticals appoints Dr. Dennis McBride to Board of Directors
---------------------------------------------------------------------

- Dr. Dennis McBride appointed to Board, effective June 13, 2024.
- Bringing neuroscience, IT, and medical technology expertise from DARPA, Navy, and academia.
- Serves as research professor at Virginia Tech; former Director of Acquisition and Innovation Research Center for DoD.
- Has experience in CNS-focused digital therapeutics with NRx founders.
- No related party transactions or arrangements were disclosed in connection with the appointment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1719406/000155837024009369/0001558370-24-009369-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1719406/000155837024009369/nrxp-20240613x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-009369

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer